Profile
Kristin Bedard served as the Chief Scientific Officer-Immuno oncology at Kineta, Inc. from 2016 to 2020.
She then worked as the Vice President-Immunobiology at Sutro Biopharma, Inc. from 2020 to 2023.
Dr. Bedard completed her undergraduate degree at The Pennsylvania State University in 1998.
She later earned her doctorate degree from the University of California, Irvine in 2005.
Former positions of Kristin Bedard
| Companies | Position | End |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Corporate Officer/Principal | 2023-05-31 |
Kineta, Inc. (Washington)
 Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Corporate Officer/Principal | 2020-01-31 |
Training of Kristin Bedard
| University of California, Irvine | Doctorate Degree |
| The Pennsylvania State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SUTRO BIOPHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kineta, Inc. (Washington)
Kineta, Inc. (Washington) Pharmaceuticals: MajorHealth Technology Kineta, Inc. engages in the development of novel immuno-therapies. It develops a pipeline of therapies that address critical unmet patient needs in oncology, chronic pain and biodefense. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Kristin Bedard
